We are a new kind of biotech company
We value efficiency in the drug discovery process, rapidly bringing high quality therapeutics to patients. We utilize multiple advanced antibody discovery platforms to empower experienced drug hunters to go efficiently from concept to IND enabling studies.
Discovering medicine is in our DNA. Our team has discovered drugs that are being used to treat patients today.
Our synergistic approach reduces the time required to optimize, develop, and produce world-class therapeutic options.
Our complementary discovery and business models are designed to support the scientists who create therapies that save lives.
Meet The Team
Our team pairs drug discovery and financial strategists for an innovative biotechnology startup model that puts scientists and patients first.
Chief Scientific Officer at Alloy Therapeutics and former Chief Scientific Officer at Compass Therapeutics.
A Special Partnership
Incubated in Alloy Therapeutics’ affiliated venture studio, Aakha.bio was created through a collaborative partnership model that leverages access to Alloy’s ATX-Gx™ transgenic mouse, suite of antibody discovery platforms, and discovery services.